Deng Mario C
Heart Failure Center and Division of Circulatory Physiology, University College of Physicians and Surgeons, New York, New York 10032, USA.
Curr Opin Cardiol. 2003 Mar;18(2):147-52. doi: 10.1097/00001573-200303000-00014.
Over the last 2 decades, mechanical circulatory support devices have been developed at a rapid pace with the goal of supporting patients with advanced heart failure as a bridge to cardiac transplantation, a bridge to recovery, and an alternative to transplantation, also called chronic or destination therapy. The current generation of devices provides a differentiated spectrum of circulatory support. The major limitations are infection, coagulopathies, and device dysfunction. The Scientific Council on Mechanical Circulatory Support of the International Society for Heart and Lung Transplantation has established an international database (http://www.ishlt.org/regist_mcsd_main.htm) to generate critical data to advance knowledge about effectiveness of mechanical circulatory support device therapy for one of the most difficult and costly contemporary medical problems, the malignant syndrome of advanced heart failure.
在过去20年里,机械循环支持设备发展迅速,目标是为晚期心力衰竭患者提供支持,作为心脏移植的桥梁、康复的桥梁以及移植的替代方案,也称为长期或终末期治疗。当前一代设备提供了不同范围的循环支持。主要局限性在于感染、凝血功能障碍和设备功能障碍。国际心肺移植学会机械循环支持科学委员会建立了一个国际数据库(http://www.ishlt.org/regist_mcsd_main.htm),以生成关键数据,推进对机械循环支持设备治疗晚期心力衰竭这一最棘手且代价高昂的当代医学问题之一的有效性的认识。